Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanisms

J Dermatolog Treat. 2006;17(3):176-8. doi: 10.1080/09546630600780494.

Abstract

We report the case of a 73-year-old man who had been on hydroxyurea for essential thrombocythemia since 1988. After 12 years of treatment he developed a symmetrical dermatomyositis-like eruption together with a leg ulceration and five squamous cell carcinomas of the face. The possible pathogenetic mechanisms of these known side effects are discussed.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Arm / pathology
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis*
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology
  • Humans
  • Hydroxyurea / administration & dosage
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use*
  • Leg Ulcer / chemically induced
  • Leg Ulcer / diagnosis*
  • Leg Ulcer / pathology
  • Male
  • Nucleic Acid Synthesis Inhibitors / administration & dosage
  • Nucleic Acid Synthesis Inhibitors / adverse effects
  • Nucleic Acid Synthesis Inhibitors / therapeutic use*
  • Thrombocytopenia / drug therapy*

Substances

  • Nucleic Acid Synthesis Inhibitors
  • Hydroxyurea